Amid steep cuts to U.S. foreign assistance, the Trump administration is touting a new plan to provide a powerful HIV prevention drug to countries most affected by the disease in an ambitious push to ...

The Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years ...

South Africa has received its first batch of the highly anticipated HIV prevention medicine Lenacapavir, marking a milestone in the country’s fight against HIV.

Lenacapavir represents a fundamental shift from traditional HIV prevention strategies, which have largely relied on daily ...

The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the ...

The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration's funding cuts to the country, a new report has found.

A noteworthy observation was the slight decline of HIV prevalence among youth aged 15-24 years from 8.7% in 2008 to 7.3% in ...

JOHANNESBURG — South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned initial ...

Spotlight meets South Africa's recently appointed Deputy Director-General for HIV, AIDS, TB and sexually transmitted infections, discussing the latest HIV prevention medicines, her career turning ...

As a twice-yearly injectable administered to HIV-negative individuals, it stands as one of the most effective pre-exposure prophylaxis (PrEP) options on offer. “This is part of integrated, ...

HARARE, Zimbabwe -- Florence Makumene held a plastic container of HIV medication and wondered if it would be her last as fears swelled of a return to a time decades ago when millions across ...